Pharmaceuticals

US Pharma and Biotech Summit 2024: 2024 Presidential Election and the Pharmaceutical Industry

bexib
By bexib 0 Min Read

In an interview with Don Tracy, Pharm Exec Associate Editor, and Robert Zirkelback, Chief Communications Officer and Director of Strategic Initiatives, PhRMA discusses the upcoming U.S. presidential election and its potential impact on the pharmaceutical industry. Talk about influence.

You Might Also Like

FDA accepts Bristol-Myers Squibb’s biologics license application for subcutaneous Opdivo in all previous indications

Theramex’s Eladinos is recommended by NICE for postmenopausal bone disease

Leqvio Demonstrates Significant Reduction of LDL-C in Patients at Risk for Atherosclerotic Cardiovascular Disease

Pharma Pulse 5/10/24: Medicare Advantage, Increased Speed ​​with Competition, Global Strategic Business Report for Anti-Obesity Drugs, and More

ICL receives £10 million donation to advance heart and lung research

Share This Article
Previous Article Chase for Business approaches innovation in stages
Next Article Seeding rates, seed-borne diseases, and trying new things, March 25, 2024 – RealAgriculture
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Stay Connected

Latest News

Sri Lanka’s Ugauragara provides a memorable outdoor dining experience called “Ugauragara no Kamata”.
Hospitality & Tourism
FinTech financing: Datadirect Networks has $ 300 million
Banking
CFPB imposes a fine of $ 2.5 million in Fintech Wise
Banking
Within the city’s cloud migration strategy
Banking